Commercial Lines
J&J Will Recall 33,000 Bottles of Baby Powder After FDA Finds Asbestos Traces
Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after the U.S. health regulators found trace amounts of asbestos in samples taken from a ...
James River Insurance Retains Rating After Dropping Its Largest Customer, Uber
Ratings agency A.M. Best said its ratings of James River Insurance remain unchanged after the insurer said it would be cancelling its business with ride-hailing giant Uber affiliate, Rasier, its ...
Brexit Business Opportunity: More Deals in Legacy General Insurance Policies
Britain's impending departure from the European Union is creating expansion opportunities for specialist general insurers who buy up and manage policies closed to new customers. Whether Britain ...
Could Your USB Cable Connect You to Hackers? — and More CM Risk Alerts
Some of the technology meant to help in your daily life may be hurting you as well. A modified USB cable could leave you connected to the bad guys. Your virtual assistant may be opening the backdoor ...
Executives On The Move at BHSI and Marsh & McLennan
Berkshire Hathaway Specialty Insurance hired veteran executives from RSA, Chubb and Allianz to fill three key leadership positions in Madrid. Marsh & McLennan made executive appointments in two ...
Hospital and Physician Liability Market Hardens Rapidly Due to Mega Claims: Aon
At first blush, it appears all is well within the hospital and physician professional liability market: For claims costing less than $2 million, severity is projected to increase 2% and frequency is ...
Berkshire Hathaway, Other Shareholders Sell Applied Underwriters Back to Founder
Applied Underwriters Inc. and its subsidiary North American Casualty Co. has reportedly been acquired by Applied Underwriters founder Steve Menzies, who was joined in the acquisition by the Quasha ...
J&J Offers $4B to Settle Opioid Claims; Distributors Agree to Pay $18B
Johnson & Johnson has offered to pay $4 billion to settle all claims accusing the company of helping fuel the U.S. opioid epidemic, as part of a potentially larger deal involving drugmakers and ...